The roles and regulation of MDM2 and MDMX: it is not just about p53

被引:101
作者
Klein, Alyssa M. [1 ]
de Queiroz, Rafaela Muniz [2 ]
Venkatesh, Divya [2 ]
Prives, Carol [2 ]
机构
[1] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY 10032 USA
[2] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
关键词
cancer; MDM2; MDM2 and MDMX inhibitors; MDMX; pathologies; roles; upstream regulation; p53;
D O I
10.1101/gad.347872.120
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Most well studied as proteins that restrain the p53 tumor suppressor protein, MDM2 and MDMX have rich lives outside of their relationship to p53. There is much to learn about how these two proteins are regulated and how they can function in cells that lack p53. Regulation of MDM2 and MDMX, which takes place at the level of transcription, post-transcription, and protein modification, can be very intricate and is context-dependent. Equally complex are the myriad roles that these two proteins play in cells that lack wild-type p53; while many of these independent outcomes are consistent with oncogenic transformation, in some settings their functions could also be tumor suppressive. Since numerous small molecules that affect MDM2 and MDMX have been developed for therapeutic outcomes, most if not all designed to prevent their restraint of p53, it will be essential to understand how these diverse molecules might affect the p53-independent activities of MDM2 and MDMX.
引用
收藏
页码:575 / 601
页数:27
相关论文
共 262 条
[1]   DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination [J].
Akande, Oluwatoyin E. ;
Damle, Priyadarshan K. ;
Pop, Marius ;
Sherman, Nicholas E. ;
Szomju, Barbara B. ;
Litovchick, Larisa, V ;
Grossman, Steven R. .
CELL REPORTS, 2019, 26 (12) :3323-+
[2]   Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1 [J].
Ambrosini, G. ;
Sambol, E. B. ;
Carvajal, D. ;
Vassilev, L. T. ;
Singer, S. ;
Schwartz, G. K. .
ONCOGENE, 2007, 26 (24) :3473-3481
[3]   Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia [J].
Andreeff, Michael ;
Kelly, Kevin R. ;
Yee, Karen ;
Assouline, Sarit ;
Strair, Roger ;
Popplewell, Leslie ;
Bowen, David ;
Martinelli, Giovanni ;
Drummond, Mark W. ;
Vyas, Paresh ;
Kirschbaum, Mark ;
Iyer, Swaminathan Padmanabhan ;
Ruvolo, Vivian ;
Gonzalez, Graciela M. Nogueras ;
Huang, Xuelin ;
Chen, Gong ;
Graves, Bradford ;
Blotner, Steven ;
Bridge, Peter ;
Jukofsky, Lori ;
Middleton, Steve ;
Reckner, Monica ;
Rueger, Ruediger ;
Zhi, Jianguo ;
Nichols, Gwen ;
Kojima, Kensuke .
CLINICAL CANCER RESEARCH, 2016, 22 (04) :868-876
[4]   Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs [J].
Anwar, Sumadi Lukman ;
Wulaningsih, Wahyu ;
Watkins, Johnathan .
CANCER BIOLOGY & MEDICINE, 2017, 14 (04) :387-395
[5]   Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53 [J].
Arena, Giuseppe ;
Cisse, Madi Yann ;
Pyrdziak, Samuel ;
Chatre, Laurent ;
Riscal, Romain ;
Fuentes, Maryse ;
Arnold, Jamie Jon ;
Kastner, Markus ;
Gayte, Laurie ;
Bertrand-Gaday, Christelle ;
Nay, Kevin ;
Angebault-Prouteau, Claire ;
Murray, Kerren ;
Chabi, Beatrice ;
Koechlin-Ramonatxo, Christelle ;
Orsetti, Beatrice ;
Vincent, Charles ;
Casas, Francois ;
Marine, Jean-Christophe ;
Etienne-Manneville, Sandrine ;
Bernex, Florence ;
Lombes, Anne ;
Cameron, Craig Eugene ;
Dubouchaud, Herve ;
Ricchetti, Miria ;
Linares, Laetitia Karine ;
Le Cam, Laurent .
MOLECULAR CELL, 2018, 69 (04) :594-+
[6]   L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes [J].
Banks, Damon ;
Wu, Min ;
Higa, Leigh Ann ;
Gavrilova, Nadia ;
Quan, Junmin ;
Ye, Tao ;
Kobayashi, Ryuji ;
Sun, Hong ;
Zhang, Hui .
CELL CYCLE, 2006, 5 (15) :1719-1729
[7]   Mdm2 and Mdm4 loss regulates distinct p53 activities [J].
Barboza, Juan A. ;
Iwakuma, Tomoo ;
Terzian, Tamara ;
El-Naggar, Adel K. ;
Lozano, Guillermina .
MOLECULAR CANCER RESEARCH, 2008, 6 (06) :947-954
[8]   Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis [J].
Bartel, F ;
Schulz, J ;
Böhnke, A ;
Blümke, K ;
Kappler, M ;
Bache, M ;
Schmidt, H ;
Würl, P ;
Taubert, H ;
Hauptmann, S .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (03) :469-475
[9]   Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase [J].
Batuello, Christopher N. ;
Hauck, Paula M. ;
Gendron, Jaimie M. ;
Lehman, Jason A. ;
Mayo, Lindsey D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (06) :1749-1754
[10]   Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery [J].
Bezzi, Marco ;
Teo, Shun Xie ;
Muller, Julius ;
Mok, Wei Chuen ;
Sahu, Sanjeeb Kumar ;
Vardy, Leah A. ;
Bonday, Zahid Q. ;
Guccione, Ernesto .
GENES & DEVELOPMENT, 2013, 27 (17) :1903-1916